⚠ Evidence warning: Clinical trials or other evidence do not support the claims that black seed suppresses or clears human immunodeficiency virus (HIV), raises antibody levels, eases ankylosing spondylitis or matches metformin. This page keeps it as a report of what people, websites or other media say.

Black Seed — Benefits Deep Dive

Benefits — scientific infographic poster

Black seed (Nigella sativa) is the small jet-black seed of an annual flowering plant in the Ranunculaceae family, native to a belt running from Eastern Europe through the Middle East to Western Asia. In the Islamic medical tradition it is called habbat al-barakah — "the seed of blessing" — based on a famous hadith attributed to the Prophet Muhammad claiming the seed is "a remedy for every disease except death." Confusingly, black seed is also widely sold as "black cumin" — but it is botanically unrelated to the regular culinary cumin (Cuminum cyminum) used in chili and curry powder. The two plants belong to different families entirely, contain completely different active compounds, and produce different clinical effects. Most of black seed's pharmacology traces back to a single principal active compound: thymoquinone, a benzoquinone monoterpene with multi-target activity across nuclear factor kappa B (NF-kB) inflammation signaling, signal transducer and activator of transcription 3 (STAT3) oncogenic signaling, AMP-activated protein kinase (AMPK) metabolic signaling, antimicrobial action, and bronchodilation. More than 1,000 published peer-reviewed papers cover black seed and thymoquinone, of which a November 2026 Europe PMC search finds 150 indexed as clinical or randomized trials, with the strongest human evidence in type 2 diabetes, asthma, rheumatoid arthritis, and metabolic syndrome. Four benefit pages below explore each of those domains in clinical detail.

Deep-Dive Articles

🛡️

Immune & Antiviral

Thymoquinone's immunomodulatory activity across innate and adaptive arms, the Islamic medical tradition of black seed as "Prophet's medicine" for every disease except death, reports of increased immunoglobulin G (IgG)/immunoglobulin M (IgM) after black seed oil supplementation, two single-patient case reports from Nigeria of human immunodeficiency virus (HIV) infection treated by a herbal therapist with black seed preparations and no antiretroviral therapy mentioned, in which the viral load was reported to fall, and the macrophage-priming and natural killer-cell effects that underpin the antiviral signal.

Read the deep dive →
🩸

Diabetes & Metabolic

Two type 2 diabetes randomized trials: Bamosa 2010 (94 patients on three doses of black seed capsules added to their diabetes drugs, compared with their own starting values) reported hemoglobin A1c (HbA1c) down 1.52 percentage points at 2 g/day over 12 weeks, no significant change at 1 g/day and no further gain at 3 g/day; Heshmati 2015 (72 patients, black seed oil 3 g/day against placebo capsules for 12 weeks) reported significant changes in fasting sugar, HbA1c, triglycerides and low-density lipoprotein. Some writers liken the effect to a moderate dose of metformin; the Bamosa report makes no such comparison. Thymoquinone's direct protection of pancreatic beta cells against streptozotocin and alloxan in animal models, the AMP-activated protein kinase activation that mimics metformin, and consistent improvements in total cholesterol, low-density lipoprotein (LDL), and triglycerides across meta-analyses of 15+ human trials.

Read the deep dive →
🫁

Asthma & Respiratory

Three asthma randomized trials: Boskabady 2007 (29 adults, a boiled seed extract against placebo for 3 months) reported better symptoms, wheezing and lung-function tests and less use of inhalers and other asthma drugs; Salem 2017 (1 or 2 g/day of black seed against placebo for 3 months) reported forced expiratory volume in one second (FEV1) rising only at 2 g/day and better asthma control scores at both doses, compared with baseline; and Koshak 2017 (black seed oil 500 mg twice daily for 4 weeks, 80 people enrolled) reported a better asthma control score with no significant change in FEV1. The histamine-release inhibition mechanism that makes thymoquinone behave like a natural mast-cell stabilizer, the bronchodilation independent of beta-2 receptor signaling, and black seed's long-standing Middle Eastern tradition for cough, bronchitis, and chest congestion.

Read the deep dive →
🦵

Inflammation & Joints

The Gheita 2012 placebo-controlled rheumatoid arthritis study, in which the same 40 women took placebo capsules for a month and then black seed oil 500 mg twice a day for a month: the Disease Activity Score in 28 joints (DAS-28) was 4.55 after the oil and 4.99 after placebo (p = 0.017), with fewer swollen joints and shorter morning stiffness. Also thymoquinone's NF-kB inhibition mechanism that down-regulates tumor necrosis factor-alpha, interleukin-1 beta (IL-1beta), interleukin-6 (IL-6), and cyclooxygenase-2 (COX-2) in parallel, reported improvement in ankylosing spondylitis on the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the question people raise of whether black seed can be used to reduce nonsteroidal anti-inflammatory drug (NSAID) dependence in chronic inflammatory arthritis.

Read the deep dive →

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. Black Seed (Sold as Black Cumin) Is Not Culinary Cumin (Cuminum cyminum)
  3. Why Black Seed Produces Effects Across So Many Systems
  4. Reported Side Effects and Drug Interactions
  5. Key Research Papers
  6. External Authoritative Resources
  7. Connections
  8. Featured Videos

Black Seed (Sold as Black Cumin) Is Not Culinary Cumin (Cuminum cyminum)

The single most common point of confusion about Nigella sativa is its name. The seed is sold throughout the United States and Europe under at least five English names: black seed, black cumin, kalonji, nigella, and Roman coriander. The Arabic name is habbat al-sawda ("the black seed") or habbat al-barakah ("the seed of blessing"). The Hindi/Urdu name is kalonji. The Persian name is siyah daneh. The botanical Latin binomial is Nigella sativa, in the buttercup family Ranunculaceae.

The catastrophically misleading name is "black cumin" — because regular culinary cumin (the spice used in chili powder, taco seasoning, Indian curries, Mexican mole, Middle Eastern hummus) is Cuminum cyminum, in the carrot family Apiaceae. These two plants:

A product labeled "black cumin oil" or "black cumin seed extract" matches the research described on this page when the Latin binomial on its label reads Nigella sativa. A label reading Cuminum cyminum means culinary cumin oil, which has no relationship to the diabetes / asthma / arthritis literature. The label wording that leaves least room for doubt is "black seed oil" with "Nigella sativa" directly underneath.

Back to Table of Contents

Why Black Seed Produces Effects Across So Many Systems

Most herbs with clinical benefit produce that benefit through one or two well-characterized active compounds acting on one or two molecular targets. Black seed is unusual because the bulk of its activity traces to a single compound — thymoquinone — that operates on at least five distinct molecular pathways with clinical relevance. Each pathway maps to one of the deep-dive pages below.

  1. NF-kB inhibition (anti-inflammatory) — in laboratory cell lines, not people, thymoquinone blocks activation of the IkappaB alpha kinase and the steps after it, including movement of the p65 part of NF-kB into the cell nucleus, and it suppresses binding of p65 to DNA, an effect that depended on one cysteine of p65 (position 38). NF-kB is the master switch for hundreds of pro-inflammatory genes — tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, cyclooxygenase-2, inducible nitric oxide synthase (iNOS). Inhibiting NF-kB simultaneously reduces all of them. This is the mechanism proposed for the rheumatoid arthritis evidence and reported ankylosing spondylitis benefit and much of the metabolic-syndrome benefit.
  2. STAT3 inhibition (anti-proliferative) — in cell and animal work, thymoquinone inhibits the constitutive activation of STAT3 found in many solid tumors. STAT3 drives cell-cycle progression, anti-apoptosis (B-cell lymphoma 2 (BCL-2), survivin), and angiogenesis (vascular endothelial growth factor (VEGF)). The STAT3 pathway accounts for most of the in-vitro and animal-model cancer signal seen with black seed extracts. Human cancer trials are limited but ongoing.
  3. AMP-activated protein kinase activation (insulin-sensitizing, metformin-like) — in cell and animal work, thymoquinone activates AMP-activated protein kinase, the same energy-sensor pathway activated by metformin and by caloric restriction. AMP-activated protein kinase activation suppresses hepatic gluconeogenesis, increases peripheral glucose uptake, and improves insulin sensitivity. This is the proposed molecular basis for the hemoglobin A1c-lowering effect reported in the Bamosa and Heshmati randomized trials.
  4. Histamine-release inhibition + bronchodilation (anti-asthmatic) — in laboratory and animal work, nigellone (the carbonyl polymer of thymoquinone) and thymoquinone itself stabilize mast cells and inhibit histamine release, similar to cromolyn sodium. Additionally, thymoquinone produces direct smooth-muscle relaxation in airway tissue independent of beta-2 receptor activation. Combined, these are offered as the explanation for the improvements in FEV1 and asthma symptom scores in the Boskabady and Salem trials.
  5. Antimicrobial and immunomodulatory activity — black seed extract is bactericidal against gram-positive and gram-negative organisms (including methicillin-resistant Staphylococcus aureus) and shows antifungal and antiparasitic activity in vitro. In laboratory and animal work thymoquinone also primes macrophages, increases natural killer (NK) cell activity, and modulates the balance of type 1 and type 2 helper T cells (Th1/Th2) — the proposed basis for the immune and antiviral signal.

A practical caveat: most of these mechanisms have been characterized at thymoquinone concentrations that may not always be achievable from oral whole-seed dosing, depending on individual gut absorption and the thymoquinone content of the specific product. What is not known is whether the blood levels reached by swallowing seed or oil come near the concentrations used in those laboratory studies: a 2017 review describes thymoquinone as having limited bioavailability and reports no human studies of thymoquinone itself. Cold-pressed black seed oil is commonly described as containing 0.4–2.5% thymoquinone by weight — a wide range offered as one explanation of why some trials show striking effects and others show none. Origin also matters: oils pressed from Ethiopian, Egyptian and Syrian seed had thymoquinone shares of 34.84%, 27.36% and 22.59% of the volatile fraction, a measure of the oil's aromatic part and not a percentage by weight of the whole oil. Some extracts are standardized and state the thymoquinone content per dose.

What pooled and recent trials found. A 2026 pooled analysis of 31 trials with 2145 people with metabolic diseases found modest changes with black seed: HbA1c down 0.56 points, fasting blood sugar down 18.62 mg/dL, systolic blood pressure down 3.25 mmHg and weight down 1.59 kg, with no effect on insulin or on the insulin-resistance score. Its authors asked for caution because study quality and outcomes varied. In asthma, a double-blind trial of black seed oil 500 mg twice daily, with 80 people enrolled and 10 leaving each group, found a better asthma control score (21.1 against 19.6 on placebo, p = 0.044) and lower blood eosinophils after 4 weeks, while lung function did not change significantly (p = 0.170).

Back to Table of Contents

Reported Side Effects and Drug Interactions

Back to Table of Contents

Key Research Papers

  1. Ahmad A et al. (2013). A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific Journal of Tropical Biomedicine. — PubMed PMID: 23646296
  2. Darakhshan S et al. (2015). Thymoquinone and its therapeutic potentials. Pharmacological Research. — PubMed PMID: 25829334
  3. Goyal SN et al. (2017). Therapeutic potential and pharmaceutical development of thymoquinone: A multitargeted molecule of natural origin. Frontiers in Pharmacology. — PubMed PMID: 28983249
  4. Sethi G et al. (2008). Targeting nuclear factor-kappaB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular Cancer Research. — PubMed PMID: 18567808
  5. Tavakkoli A et al. (2017). Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. Journal of Pharmacopuncture. — PubMed PMID: 30087794
  6. Gheita TA, Kenawy SA (2012). Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytotherapy Research. — PubMed PMID: 22162258
  7. Bamosa AO et al. (2010). Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian Journal of Physiology and Pharmacology. — PubMed PMID: 21675032
  8. Heshmati J et al. (2015). Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Food Research International. — doi:10.1016/j.foodres.2015.01.030
  9. Musazadeh V et al. (2026). The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE-Assessed Systematic Review and Meta-Analysis. Endocrinology, Diabetes & Metabolism. — PubMed PMID: 41858302
  10. Boskabady MH et al. (2007). The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients. Fundamental & Clinical Pharmacology. — PubMed PMID: 17868210
  11. Salem AM et al. (2017). Effect of Nigella sativa supplementation on lung function and inflammatory mediators in partly controlled asthma: a randomized controlled trial. Annals of Saudi Medicine. — PubMed PMID: 28151459
  12. Koshak A et al. (2017). Nigella sativa Supplementation Improves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial. Phytotherapy Research. — PubMed PMID: 28093815
  13. Onifade AA, Jewell AP, Adedeji WA (2013). Nigella sativa concoction induced sustained seroreversion in HIV patient. African Journal of Traditional, Complementary and Alternative Medicines. Single-patient case report. — PubMed PMID: 24311845
  14. Onifade AA, Jewell AP, Okesina AB (2015). Seronegative conversion of an HIV positive subject treated with Nigella sativa and honey. African Journal of Infectious Diseases. Single-patient case report. — doi:10.4314/ajid.v9i2.6
  15. Abdel-Razek AG et al. (2024). Assessment of the Quality, Bioactive Compounds, and Antimicrobial Activity of Egyptian, Ethiopian, and Syrian Black Cumin Oils. Molecules. — PubMed PMID: 39519627
  16. Zhivov E, Johnston C, Shangraw S (2024). Nigella Sativa (Black Cumin) Oil: A Case Report and Analysis Exploring Severe Cutaneous Manifestations and Implications for Patient Care. Journal of Clinical and Aesthetic Dermatology. — PubMed PMID: 39759250
  17. Arab A, Ramezaninejad S, Salehifar E (2026). Extensive Subcutaneous Hematoma in a Patient Receiving Nigella sativa Oil, Dual Antiplatelet Therapy, and Oxaliplatin-Based Chemotherapy: A Case Report. Hospital Pharmacy. — PubMed PMID: 42682876

PubMed Topic Searches

  1. PubMed: Nigella sativa thymoquinone clinical trials
  2. PubMed: Thymoquinone NF-kB inflammation
  3. PubMed: Black seed oil human trials
  4. PubMed: Nigella sativa mechanism & pharmacology
  5. PubMed: Thymoquinone STAT3 / AMPK signaling

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents